IGM Cost Of Revenue from 2010 to 2024
| IGMS Stock | USD 10.04 0.39 3.74% |
Cost Of Revenue | First Reported 2010-12-31 | Previous Quarter 8.3 M | Current Value 8 M | Quarterly Volatility 5.1 M |
Check IGM Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IGM Biosciences' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 8.7 M or Interest Expense of 8.3 M, as well as many indicators such as Price To Sales Ratio of 194, Dividend Yield of 0.0 or PTB Ratio of 2.25. IGM financial statements analysis is a perfect complement when working with IGM Biosciences Valuation or Volatility modules.
IGM | Cost Of Revenue |
Latest IGM Biosciences' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of IGM Biosciences over the last few years. Cost of Revenue is found on IGM Biosciences income statement and represents the costs associated with goods and services IGM Biosciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is IGM Biosciences' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IGM Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
IGM Cost Of Revenue Regression Statistics
| Arithmetic Mean | 7,250,299 | |
| Geometric Mean | 6,207,134 | |
| Coefficient Of Variation | 69.85 | |
| Mean Deviation | 3,533,426 | |
| Median | 4,397,000 | |
| Standard Deviation | 5,064,593 | |
| Sample Variance | 25.7T | |
| Range | 19.1M | |
| R-Value | 0.43 | |
| Mean Square Error | 22.6T | |
| R-Squared | 0.18 | |
| Significance | 0.11 | |
| Slope | 482,905 | |
| Total Sum of Squares | 359.1T |
IGM Cost Of Revenue History
About IGM Biosciences Financial Statements
IGM Biosciences shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although IGM Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in IGM Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on IGM Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 8.3 M | 8 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.